Drug firms fined in Medicaid fraud
- Share via
From Times Wire Reports
A Montgomery jury found that two major pharmaceutical companies defrauded the state in a long-running Medicaid drug-pricing scheme and ordered the firms to pay more than $114 million in damages.
The jury found that Glaxo- SmithKline should pay $80.8 million in compensatory damages and that Novartis should pay about $33.7 million in similar damages.
It declined to order punitive damages.
The companies were deciding whether to appeal.
Inside the business of entertainment
The Wide Shot brings you news, analysis and insights on everything from streaming wars to production — and what it all means for the future.
You may occasionally receive promotional content from the Los Angeles Times.
